Loading clinical trials...
Loading clinical trials...
This is a safety, tolerability, and pharmacokinetics study of bimatoprost in male patients with androgenetic alopecia (AGA).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Allergan
NCT07502976 · Androgenic Alopecia
NCT07029711 · Severe Alopecia Areata
NCT07435012 · Androgenic Alopecia
NCT07080931 · Androgenetic Alopecia
NCT06826196 · Alopecia Areata (AA)
DermResearch, LLC
Austin, Texas
J&S Studies Inc.
College Station, Texas
E&R Research Foundation
Lynchburg, Virginia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions